Apotex Inc. v. Astrazeneca Canada Inc., 2017 FCA 9
Linked as:
Extract
Apotex Inc. v. Astrazeneca Canada Inc., 2017 FCA 9
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 222 F.Supp.2d 423 (S.D.N.Y. 2002), 99 Civ. 8926, Astra Aktiebolag v. Andrx Pharmaceuticals, Inc.
- Federal Cases - 490 F.Supp.2d 381 (S.D.N.Y. 2007), 00 Civ. 6749, In re Omeprazole Patent Litigation
- Federal Cases - 536 F.3d 1361 (Fed. Cir. 2008), 2007-1414, In re Omeprazole Patent Litigation
- AstraZeneca Canada Inc. et al. v. Apotex Inc., [2015] F.T.R. Uned. 305 (FC)
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)